InvestorsHub Logo
icon url

Dall21

01/02/21 6:49 AM

#338514 RE: Bottom Feedr #338512

Find Farrell90's post from 12/23 . It's a very clear road map of the direction of this Company. IMO.
icon url

roiresearch

01/02/21 9:07 AM

#338517 RE: Bottom Feedr #338512

Ipix perked up again this year because of Covid

Covid plays are still hot... just like EV and Bitcoin

The Covid data so far seems good for IPIX, but it's preclinical. Right now we are the turning point of getting into human trials. It's a risk/reward play. Will our lead Covid drug candidate do well in human trials? That's a gamble you have to make

Other reasons why the stock is not yet in rally mode. The company PRs are not very direct, but give more or less a general idea. Many times investors are left with more questions then answers. The time frames given in company PRs are not to be relied upon. The company disappears when bad news arises. Toxic financing has hurt the share price without concrete news to back it up.

Positives include our now active IND, a pre-print out of George Mason Univ and Rutgers covering our lead Covid drug (however not peer reviewed yet), cash in the bank, Covid drug has already been manufactured, several CROs in place (domestic and overseas) to start trials

Speculation include grant money, new partner/collaborator, update on other indications, good P2 results, new arms included in clinical studies for pan-coronavirus, new pre-prints coming out on lead Covid candidate

Happy New Year
icon url

shazamm

01/02/21 11:19 AM

#338528 RE: Bottom Feedr #338512

Here ya go bottom feedr,

Farrell’s 12/23 post

I am looking forward to the coming year. New investors need to read the PR's from the initial 2/18/2020 announcement of Brilacidin for Covid 19 to the announcement of human clinical trials on 12/21/2020.

What they will find is a logical progression of basic scientific research where each success is built upon leading to additional study and success until the clinical trial announcement.In vitro testing conclusively demonstrates Brilacidin is one of the most promising therapeutics for Covid 19. This body of work is leading to human clinical trials where Brilacidin will be given to humans sick with Covid 19. It is a remarkable achievement for such a small company

http://www.ipharminc.com/press-release

-2/18 Initial announcement of Brilacidin for Covid 19
-2/24 Material transfer agreements to virology labs
-2/28 Brilacidin sent to Regional Biodefense Labs {RBL)for study
-3/2 Brilacidin PDF outlines scientific rationale for use against Covid19
-3/9 Brilacidin studies planned at RBL
-3/12 Testing to begin 3/16
-4/1 Brilacidin effective against Covid19 in Vero monkey cells
-4/6 Early discussions of human trials
-4/20 Screening of 11,552 compounds shows Brilacidin a leading drug against Covid19 by inhibiting the M-protease
-4/27 Initial research confirms anti Covid properties more research planned
-5/5 PHRI studies announced
-5/19 Brilacidin reduces Covid 75% in preincubtion Vero cell study
-5/26 Brilacidin reduces Covid in human renal cell line; blocks viral cell entry
-6/11 Brilacidin study to include MERS and SARS pan corona virus testing; Grant application application made
-6/17 Brilacidin inhibits Covid 97% in infected Human respiratory cells
-7/7 Brilacidin active against Covid 19 before during and after Covid infects cells
-7/13 Human clinical trial planning/manufacture of Brilacidin announced
-7/20 Brilacidin at low dosage is effective against Covid19; lower than ABSSI dose
-8/4 Brilacidin shown effective against entire Covid life cycle
-8/24 Brilacidin Selectivity index among highest reported
-8/26 Dr Degrado announced as science advisor
-9/15 Brilacidin synergistic with remdesivir;reduces viral load almost 100%
-10/2 Pre IND meeting; Brilacidin human clinical trials
-10/30 RBL preprint article released; Selectivity index 426 one of highest achieved
-11/2 FDA pre IND response received;CRO secured
-11/16 Overseas CTA submitted;Brilacidin viral resistance unlikely
-11/30 New research for Brilacidin as a pancoronavirus treatment
FDA application submitted
-12/21 Brilacidin for phase 2 Covid study approved

Where some see lies and deceit, I see scientific advancement,diligence and competence resulting in success.

Good luck to all,

Farrell
icon url

TheDane

01/02/21 7:34 PM

#338556 RE: Bottom Feedr #338512

Find your own reasons!!! Buy no mater what!!!